Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ascorbic Acid | 5 | 2008 | 13 | 0.540 |
Why?
|
| Vasculitis | 2 | 2014 | 4 | 0.530 |
Why?
|
| Protein Disulfide-Isomerases | 2 | 2013 | 4 | 0.530 |
Why?
|
| Macrophage-1 Antigen | 2 | 2014 | 4 | 0.450 |
Why?
|
| Neutrophil Infiltration | 1 | 2013 | 3 | 0.420 |
Why?
|
| Melanoma, Experimental | 2 | 2007 | 4 | 0.340 |
Why?
|
| Mice | 11 | 2014 | 219 | 0.320 |
Why?
|
| Animals | 12 | 2014 | 762 | 0.310 |
Why?
|
| Cell Cycle | 1 | 2007 | 6 | 0.290 |
Why?
|
| Neutrophils | 3 | 2014 | 11 | 0.240 |
Why?
|
| Reactive Oxygen Species | 5 | 2007 | 14 | 0.210 |
Why?
|
| Blood Platelets | 2 | 2013 | 17 | 0.200 |
Why?
|
| Interleukin-18 | 3 | 2004 | 6 | 0.170 |
Why?
|
| Apoptosis | 5 | 2007 | 32 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2014 | 43 | 0.160 |
Why?
|
| Melanoma | 3 | 2008 | 8 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2008 | 20 | 0.150 |
Why?
|
| Humans | 8 | 2014 | 2073 | 0.140 |
Why?
|
| Caspases | 3 | 2007 | 11 | 0.120 |
Why?
|
| Male | 3 | 2014 | 1131 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2013 | 91 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 7 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2007 | 71 | 0.110 |
Why?
|
| Hemostasis | 1 | 2013 | 2 | 0.110 |
Why?
|
| Thrombosis | 1 | 2013 | 8 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2013 | 4 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2013 | 7 | 0.110 |
Why?
|
| Ligands | 1 | 2013 | 9 | 0.110 |
Why?
|
| Cell Adhesion | 1 | 2013 | 8 | 0.110 |
Why?
|
| Protein Binding | 1 | 2013 | 22 | 0.100 |
Why?
|
| Inflammation | 1 | 2013 | 17 | 0.100 |
Why?
|
| Rats | 1 | 2013 | 160 | 0.100 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 3 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 61 | 0.090 |
Why?
|
| fas Receptor | 2 | 2007 | 4 | 0.090 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 10 | 0.080 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2008 | 2 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 5 | 0.080 |
Why?
|
| Skin Neoplasms | 2 | 2005 | 6 | 0.080 |
Why?
|
| Antioxidants | 2 | 2005 | 10 | 0.080 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2007 | 2 | 0.070 |
Why?
|
| G1 Phase | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 6 | 0.070 |
Why?
|
| Burkitt Lymphoma | 1 | 2007 | 2 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 2 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 4 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 18 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2005 | 19 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2007 | 2 | 0.070 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Liver | 1 | 2007 | 8 | 0.070 |
Why?
|
| Insulin | 1 | 2007 | 8 | 0.070 |
Why?
|
| Genetic Therapy | 1 | 2007 | 18 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2008 | 18 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 57 | 0.060 |
Why?
|
| Mitochondria | 2 | 2003 | 12 | 0.060 |
Why?
|
| Receptors, Transferrin | 1 | 2005 | 2 | 0.060 |
Why?
|
| Iron | 1 | 2005 | 5 | 0.060 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2004 | 3 | 0.060 |
Why?
|
| Microglia | 1 | 2004 | 6 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2007 | 39 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 28 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 3 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2004 | 4 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2004 | 8 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2003 | 3 | 0.060 |
Why?
|
| Keratinocytes | 1 | 2002 | 2 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 7 | 0.050 |
Why?
|
| Antigens, Surface | 1 | 2002 | 3 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2011 | 15 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 12 | 0.030 |
Why?
|
| Pyridines | 2 | 2008 | 9 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 26 | 0.030 |
Why?
|
| Imidazoles | 2 | 2008 | 12 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 13 | 0.030 |
Why?
|
| Talin | 1 | 2014 | 2 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cell Communication | 1 | 2014 | 5 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2014 | 4 | 0.030 |
Why?
|
| Fibrin | 1 | 2013 | 2 | 0.030 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2013 | 3 | 0.030 |
Why?
|
| Shear Strength | 1 | 2013 | 3 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 10 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2014 | 62 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2013 | 26 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2013 | 25 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 98 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2013 | 6 | 0.030 |
Why?
|
| Caspase 8 | 2 | 2003 | 4 | 0.030 |
Why?
|
| Caspase 9 | 2 | 2003 | 4 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 18 | 0.030 |
Why?
|
| Calcium | 1 | 2013 | 191 | 0.020 |
Why?
|
| Pseudopodia | 1 | 2011 | 2 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2011 | 2 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2011 | 3 | 0.020 |
Why?
|
| Microcirculation | 1 | 2011 | 4 | 0.020 |
Why?
|
| Megakaryocytes | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2011 | 33 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 6 | 0.020 |
Why?
|
| Vitamins | 1 | 2008 | 3 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2007 | 2 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2007 | 2 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2007 | 2 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2005 | 2 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 6 | 0.020 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2004 | 2 | 0.010 |
Why?
|
| Titrimetry | 1 | 2004 | 3 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2004 | 4 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 3 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2004 | 6 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2004 | 3 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 25 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 2 | 0.010 |
Why?
|
| Acetylcysteine | 1 | 2003 | 3 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2003 | 3 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 20 | 0.010 |
Why?
|
| Oxidants | 1 | 2003 | 2 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2003 | 2 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 149 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2003 | 88 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2002 | 3 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cell Line | 1 | 2002 | 50 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 61 | 0.010 |
Why?
|
| CD48 Antigen | 1 | 2002 | 2 | 0.010 |
Why?
|
| Palatine Tonsil | 1 | 2002 | 2 | 0.010 |
Why?
|
| Trihexosylceramides | 1 | 2002 | 2 | 0.010 |
Why?
|
| Neprilysin | 1 | 2002 | 2 | 0.010 |
Why?
|
| Antigens, CD20 | 1 | 2002 | 2 | 0.010 |
Why?
|
| CD40 Antigens | 1 | 2002 | 2 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2002 | 2 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2002 | 2 | 0.010 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 6 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2002 | 14 | 0.010 |
Why?
|